Dmitry Balyasny Balyasny Asset Management
Dmitry Balyasny is the founder of Balyasny Asset Management, a major multi-strategy and multi-manager hedge fund platform. The firm allocates capital across fundamental equities, macro, quant, and other teams under a central risk framework. Balyasny’s platform is often cited alongside other leading pod-shop multi-strategy firms.
Top Buys
| Rank | Stock | Value |
|---|---|---|
| 1 |
BAS
Basis Energy Services, Inc.
BAS
|
+$159M |
| 2 |
Freeport-McMoran
FCX
|
+$137M |
| 3 |
Walt Disney
DIS
|
+$129M |
| 4 |
Alcoa
AA
|
+$98.7M |
| 5 |
CMA
Comerica
CMA
|
+$87.4M |
Top Sells
| Rank | Stock | Value |
|---|---|---|
| 1 |
Eli Lilly
LLY
|
+$187M |
| 2 |
TWX
Time Warner Inc
TWX
|
+$177M |
| 3 |
ANDV
Andeavor
ANDV
|
+$166M |
| 4 |
Canadian Pacific Kansas City
CP
|
+$160M |
| 5 |
Union Pacific
UNP
|
+$140M |
Sector Composition
| Rank | Sector | Weight |
|---|---|---|
| 1 | Financials | 14.65% |
| 2 | Consumer Discretionary | 12.25% |
| 3 | Healthcare | 12.08% |
| 4 | Energy | 7.79% |
| 5 | Materials | 6.61% |
| Name | Market Value | Portfolio Weight | Shares or Principal |
Change in Stake | Capital Flow | |
|---|---|---|---|---|---|---|
|
USG
1126
DELISTED
Usg
USG
| $550K | ﹤0.01% |
19,034
+6,539
| +52% | +$180K |
|
1127
Builders FirstSource
BLDR
$7.57B
| $549K | ﹤0.01% |
50,000
-130,612
| -72% | -$1.42M |
|
1128
Boston Beer
SAM
$1.93B
| $546K | ﹤0.01% |
+3,213
| New | +$532K |
|
|
TXNM
1129
TXNM Energy Inc
TXNM
$5.89B
| $546K | ﹤0.01% |
15,931
-268,973
| -94% | -$8.73M |
|
1130
NETGEAR
NTGR
$569M
| $538K | ﹤0.01% |
+9,896
| New | +$528K |
|
1131
NCR Voyix
VYX
$1.1B
| $538K | ﹤0.01% |
21,604
-5,063
| -19% | -$114K |
|
1132
Automatic Data Processing
ADP
$113B
| $537K | ﹤0.01% |
+5,225
| New | +$488K |
|
|
ISBC
1133
DELISTED
Investors Bancorp, Inc.
ISBC
| $537K | ﹤0.01% |
+38,487
| New | +$503K |
|
1134
West Pharmaceutical
WST
$24.7B
| $534K | ﹤0.01% |
+6,300
| New | +$495K |
|
1135
Newmont
NEM
$138B
| $531K | ﹤0.01% |
+15,576
| New | +$532K |
|
1136
Liberty Latin America Class C
LILAK
$1.65B
| $529K | ﹤0.01% |
+29,205
| New | +$586K |
|
1137
Lincoln National
LNC
$8.15B
| $529K | ﹤0.01% |
7,980
-350,109
| -98% | -$20.4M |
|
|
ACH
1138
Accendra Health
ACH
$87.7M
| $523K | ﹤0.01% |
+14,828
| New | +$501K |
|
1139
Diamondback Energy
FANG
$57.1B
| $519K | ﹤0.01% |
+5,135
| New | +$513K |
|
|
SE
1140
DELISTED
Spectra Energy Corp Wi
SE
| $510K | ﹤0.01% |
+12,410
| New | +$514K |
|
1141
LyondellBasell Industries
LYB
$21.1B
| $509K | ﹤0.01% |
5,938
-1,092,983
| -99% | -$91.7M |
|
1142
Avis
CAR
$5.22B
| $506K | ﹤0.01% |
+13,799
| New | +$500K |
|
1143
Designer Brands
DBI
$302M
| $501K | ﹤0.01% |
22,140
+1,972
| +10% | +$44.7K |
|
1144
CenterPoint Energy
CNP
$25.7B
| $495K | ﹤0.01% |
20,070
-46,548
| -70% | -$1.09M |
|
1145
Murphy Oil
MUR
$5.14B
| $495K | ﹤0.01% |
+15,890
| New | +$481K |
|
1146
Hecla Mining
HL
$13.7B
| $494K | ﹤0.01% |
+94,285
| New | +$553K |
|
|
BBBY
1147
DELISTED
Bed Bath & Beyond Inc
BBBY
| $489K | ﹤0.01% |
+12,035
| New | +$522K |
|
1148
Berkshire Hathaway Class A
BRK.A
$1.07T
| $488K | ﹤0.01% |
+2
| New | +$462K |
|
|
HZNP
1149
DELISTED
Horizon Therapeutics Public Limited Company Ordinary Shares
HZNP
| $485K | ﹤0.01% |
+29,984
| New | +$544K |
|
|
RRD
1150
DELISTED
RR Donnelley & Sons Co.
RRD
| $480K | ﹤0.01% |
+29,403
| New | +$528K |
|
Similar funds
Dmitry Balyasny's Q4 2016 Portfolio in Review
As of Q4 2016, Dmitry Balyasny held 1,603 positions worth $18.6B, up 7.6% from $17.3B the previous quarter. Its ten largest holdings account for 8.7% of the portfolio.
Dmitry Balyasny's Q4 2016 filing shows 632 new, 338 increased, 353 reduced and 276 closed positions. Its largest new stake was Basis Energy Services, Inc.: 586,398 shares worth $20.7M. The largest sale was Eli Lilly, an estimated $187M.
By sector, the portfolio is most concentrated in Financials at 15% of assets, up from 9.6% a quarter earlier, followed by Consumer Discretionary and Healthcare.
- Dmitry Balyasny's largest Q4 2016 buy was Basis Energy Services, Inc.: 586,398 shares worth $20.7M.
- Dmitry Balyasny added most to Alcoa in Q4 2016, an estimated $98.7M increase.
- Dmitry Balyasny's biggest Q4 2016 reduction was Eli Lilly, cutting an estimated $187M.
- Dmitry Balyasny fully exited Canadian Pacific Kansas City in Q4 2016, selling an estimated $160M.
- Dmitry Balyasny's ten largest holdings make up 8.7% of its $18.6B portfolio in Q4 2016.
- Dmitry Balyasny opened 632 new positions and closed 276 in Q4 2016.
- Dmitry Balyasny's portfolio value rose 7.6% quarter-over-quarter to $18.6B.
Based on Balyasny Asset Management's 13F filing for Q4 2016, filed 14 Feb 2017.